Target intelligence / Profile preview

HYDIN pseudogene 1 (HYDINP1)

Target
HYDINP1
Molecular classification
Other, Pseudogene
01

Overview

HYDIN pseudogene 1 (HYDINP1) is classified as a pseudogene, meaning it is a DNA sequence similar to a known gene (in this case, HYDIN) but is non-functional and does not encode a protein[5]. It is not a receptor, enzyme, transporter, or other actionable therapeutic target. Pseudogenes can sometimes be transcriptionally active or have regulatory roles but are generally not considered therapeutically relevant molecular targets; current databases and genetic resources do not associate HYDINP1 with any known protein product, drug interactions, or roles in disease. The functional HYDIN gene, in contrast, encodes a ciliary protein associated with primary ciliary dyskinesia; HYDINP1 is unrelated to this pathology other than sharing homology[1][2][3][5]. There is no evidence for pharmacological targeting, validated biomarkers, or disease implication for HYDINP1. The principal issue with queries about this molecule as a receptor or therapeutic target is that it is a pseudogene and not a functional gene product[5].

Other names
HYDINP1HYDIN pseudogene 1

Beyond the preview

Go deeper on HYDIN pseudogene 1 (HYDINP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HYDIN pseudogene 1 (HYDINP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call